semaglutide fda approval history Approves for New Indication Involving Cardiovascular Disease With FDA approval of Wegovy

Understanding GLP-1 Injections: A Powerful Tool for Sustainable Weight Loss GLP-1 (glucagon-like peptide-1) receptor agonistslike semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro)are part of a class of medications that mimic a natural hormone in your body

PlexusDx offers both medications in injectable and oral forms, compounded by licensed 503A pharmacies

The GLP-1 class includes drugs FDA-approved for type 2 diabetes (since exenatide in 2005) and for chronic weight management (liraglutide / Saxenda in 2014)

DOI: 10.1126/science.1260419 [Google Scholar] Salminen A

All information on this page is a summary of peer-reviewed scientific literature and does not constitute medical advice

This highlights the need for further research to distinguish between the risk of developing an autoimmune phenotype and the risk of progressing to severe clinical manifestations like TED. While the research teams findings suggest a protective association between GLP-1 drug therapy and TED, the underlying biological pathways remain speculative